📗 Cite This Artifact
ID: hypothesis-h-826df660
Hypothesis
Optogenetic Control of Mitochondrial Transfer Networks
Light-activated ion channels in astrocytes trigger calcium influx that stimulates tunneling nanotube formation and mitochondrial export on demand, providing temporal and spatial control.
EvidencePending (0%)📖 17 cit🗣 3 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
Light-activated ion channels in astrocytes trigger calcium influx that stimulates tunneling nanotube formation and mitochondrial export on demand, providing temporal and spatial control.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
graph TD
A["Channelrhodopsin-2 in Astrocytes"] --> B["Blue Light Stimulation"]
B --> C["Controlled Ca2+ Influx"]
C --> D["Tunneling Nanotube Formation"]
D --> E["Mitochondrial Transfer to Neurons"]
F["Damaged Neurons"] --> G["Mitochondrial Dysfunction"]
G --> H["ATP Depletion"]
G --> I["ROS Accumulation"]
E --> J["Healthy Mito Integration"]
J --> K["Restored ATP Production"]
J --> L["Normalized ROS Levels"]
K --> M["Neuronal Rescue"]
L --> M
N["Optogenetic Advantages"] --> O["Temporal Precision"]
N --> P["Spatial Precision"]
N --> Q["Dose Control via Light"]
O --> R["Triggered On-Demand"]
P --> S["Target Specific Brain Regions"]
Q --> T["Titrate Transfer Rate"]
R --> U["Precision Neuroprotection"]
S --> U
T --> U
style A fill:#1a3a4a,stroke:#4fc3f7,color:#e0e0e0
style F fill:#4a1942,stroke:#ce93d8,color:#e0e0e0
style J fill:#1a3a2a,stroke:#81c784,color:#e0e0e0
style U fill:#2a3a1a,stroke:#c5e1a5,color:#e0e0e0⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
Supports
Calcium elevation promotes tunneling nanotube formation and mitochondrial transfer
Supports
Light-controlled mitochondrial transport has been demonstrated in cellular models
Contradicts
Sustained optogenetic activation leads to cellular toxicity and reduced astrocyte viability
Contradicts
Light delivery to deep brain structures requires invasive fiber optic implantation with associated risks
Contradicts
Calcium-induced tunneling nanotube formation is transient and may not support sustained mitochondrial transfer
📖 Linked Papers (16)Export BibTeX ↗
Harlequin syndrome associated with thoracic epidural anaesthesia.
Anaesthesia reports (2022) · PubMed:35118419 ↗
1 figure
Figures
Figures available at source paper (no open-access XML found).
Transmission dynamics of a linear vanA-plasmid during a nosocomial multiclonal outbreak of vancomycin-resistant enterococci in a non-endemic area, Japan.
Scientific reports (2021) · PubMed:34285270 ↗
8 figures

Figure 1
Minimum inhibitory concentration of vancomycin and teicoplanin for vancomycin-resistant Enterococcus faecium isolates during the outbreak. According to the cr...

Figure 2
Dendrogram of pulsotypes in pulsed-field gel electrophoresis and sequence types in multilocus sequence typing among vancomycin-resistant Enterococcus faecium ...
High resolution spatiotemporal patterns of seawater temperatures across the Belize Mesoamerican Barrier Reef.
Scientific data (2020) · PubMed:33199700 ↗
3 figures

Fig. 1
Map of logger deployment sites in Belize.

Fig. 2
Cross-sectional view of Carrie Bow Caye describing back reef and the two fore reefs in this area: inner fore reef and outer fore reef.
Enhancer AAVs for targeting spinal motor neurons and descending motor pathways in rodents and macaque
Cell Reports (2025) · PubMed:40403722 ↗
No figures
Sodium-Selective Channelrhodopsins.
Cells (2024) · PubMed:39594600 ↗
No figures
Optogenetic manipulation of lysosomal physiology and autophagy-dependent clearance of amyloid beta.
PLoS Biol (2024) · PubMed:38652732 ↗
No figures
Auditory nerve responses to combined optogenetic and electrical stimulation in chronically deaf mice.
J Neural Eng (2023) · PubMed:36963106 ↗
No figures
Applications and challenges of rhodopsin-based optogenetics in biomedicine.
Front Neurosci (2022) · PubMed:36213746 ↗
No figures
Optogenetic Studies of Mitochondria.
Methods in molecular biology (Clifton, N.J.) (2022) · PubMed:35857235 ↗
No figures
Isolation and Crystallization of the D156C Form of Optogenetic ChR2.
Cells (2022) · PubMed:35269517 ↗
No figures
📙 Related Wiki Pages (15)
Mitochondrial TherapeuticstherapeuticAstrocytic Mitochondrial Transfer TheraptherapeuticMitochondrial Dynamics Modulators for NetherapeuticSection 204: Advanced Proteostasis and PtherapeuticMitochondrial Support Strategies for CBStherapeuticMitochondrial Biogenesis InducerstherapeuticA Phase 2b, Multicenter, Randomized, DouclinicalA Phase 2 Double-Blind, Randomized, PlacclinicalA 6-month & 18-month Prospective, RandomclinicalOptogenetically-Modified Neurons in NeurcellA Phase IIB, Randomized, Double-Blind, PclinicalSynaptic Therapy Alzheimer's Research TrclinicalA Phase III, Randomized, Double-Blind, PclinicalA Multicenter, Phase III, Randomized, DoclinicalKAT2B Protein — Lysine Acetyltransferaseprotein
🏥 Translation
🧬 3D Protein Structure — CHR2
No curated PDB or AlphaFold mapping for CHR2 yet. Search RCSB →
💉 Clinical Trials (5)Relevance: 38%
0
Active
Active
0
Completed
Completed
1,240
Total Enrolled
Total Enrolled
PHASE1
Highest Phase
Highest Phase
UNKNOWN·NCT04887675 · University of Novi Sad
120 enrolled · 2021-05-01 · → 2022-06-01
Since the HIV changed its course to the chronic disease, high incidence of metabolic syndrome both in HIV positive and negative subjects has become an issue. Given the successful peripheral suppressio
HIV I Infection HIV Associated Lipodystrophy Metabolic Syndrome
MRI
ENROLLING_BY_INVITATION·NCT06875739 · Fondazione Don Carlo Gnocchi Onlus
310 enrolled · 2025-02-14 · → 2026-10-01
The aim of the study is to validate a salivary test that allows for rapid and accurate objective diagnosis in the context of neurodegenerative diseases, a complex of diseases that includes Alzheimer's
Neurodegenerative Disorders Parkinson Disease Alzheimer Disease
RECRUITING·NCT00029965 · National Human Genome Research Institute (NHGRI)
200 enrolled · 2002-02-06
Study description:
This is a natural history study that will evaluate any patient with enzyme or DNA confirmed GM1 or GM2 gangliosidosis, sialidosis or galactosialidosis. Patients may be evaluated ev
Neurological Regression Myoclonus Cherry Red Spot
COMPLETED·NCT04281186 · Hospital Universitari Vall d'Hebron Research Institute
510 enrolled · 2020-11-16 · → 2024-12-12
The retina shares similar embryologic origin, anatomical features and physiological properties with the brain and hence offers a unique and accessible "window" to study the correlates and consequences
Retinal Function Cognitive Dysfunction Microperimetry
UNKNOWN·NCT04248270 · Chang Gung Memorial Hospital
100 enrolled · 2020-02-20 · → 2023-08-17
Dementia is a clinical syndrome which characterized by progressive cognitive impairment, behavior disturbance and dysfunction of daily activity. In aging population, Alzheimer's dementia (AD) is the m
Alzheimer's Disease Vascular Dementia Dementia
18F-PM-PBB3
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for ChR2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
3.0 years
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0565
Events (7d)
0
Price History
▲22.6%💾 Resource Usage
LLM Tokens
39,356
$0.2361
Total Cost
$0.2361
🧭 Related
🕸 Knowledge Subgraph (31 edges)Centered on ChR2
Top relations:causes (9)regulates (5)risk factor for (4)modulates (3)protective against (3)facilitates (2)
🔍 Show all 31 edges across 11 relations
activates (1)
causal extracted (1)
causes (9)
facilitates (2)
modulates (3)
prevents (1)
protective against (3)
regulates (5)
risk factor for (4)
therapeutic target for (1)
🗺️ KG Entities (41)
BNIP3/NIXBNIP3/NIX inhibitionConnexin-43Connexin-43 deficiencyF-actinMiro1Miro1 degradationMiro1 dysfunctionParkinson's diseaseastrocyte-to-neuron mitochondrial tranastrocytesbioenergetically compromised neuronscalcium homeostasis disruptioncardiac arrhythmiascellular toxicityconnexin-43damaged mitochondrial spreadenhanced mitochondrial motilityexcessive Connexin-43 expressionexcessive connexin-43 expressiongap junction communicationgap junction coupling excesshealthy mitochondria preservationinsufficient mitophagyintercellular mitochondrial transferintercellular organelle transfermitochondrial motility enhancementmitochondrial transfermitochondrial transfer efficiencymitochondrial turnovermitophagymitophagy insufficiencyneurodegenerationneuronal bioenergeticsneuronal survivaloxidative stressprocessedseizuressess_SDA-2026-04-01-gap-20260401231108tunneling nanotube formationtunneling nanotubes
🧪 Adjacent Hypotheses6 siblings from the same analysis
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective Mitochondrial Donation
0.68GJA1 · neurodegeneration · proposed
Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy
0.55RHOT1 · neurodegeneration · proposed
PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor Mitochondria
0.53BNIP3/BNIP3L · neurodegeneration · proposed
Synthetic Biology Approach: Designer Mitochondrial Export Systems
0.51Synthetic fusion proteins · neurodegeneration · proposed
Microglia-Derived Extracellular Vesicle Engineering for Targeted Mitochondrial Delivery
0.48RAB27A/LAMP2B · neurodegeneration · archived
Gap Junction Hemichannel Modulation for Controlled Mitochondrial Exchange
0.36PANX1 · neurodegeneration · archived
🗣 Debate PerspectivesGap Analysis | 5 rounds | 2026-04-01
🔮 Predictions
🔎 Predictions vs Observations4 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| If hypothesis is true, intervention be implemented. Initial in vitro studies would utilize primary astrocyte-neuron co-cultures transduced with AAV vectors expressing ChR2 under the GFAP promoter | be implemented. Initial in vitro studies would utilize primary astrocyte-neuron co-cultures transduced with AAV vectors expressing ChR2 under the GFAP promoter | — no observation — | pending | 0.40 |
| If hypothesis is true, intervention potentially be harnessed for therapeutic intervention | potentially be harnessed for therapeutic intervention | — no observation — | pending | 0.40 |
| If hypothesis is true, intervention induce calcium elevations sufficient to trigger gliotransmitter release and influence synaptic transmission | induce calcium elevations sufficient to trigger gliotransmitter release and influence synaptic transmission | — no observation — | pending | 0.40 |
| If hypothesis is true, intervention track mitochondrial movement using fluorescent indicators (MitoTracker Red, mito-GFP) while simultaneously monitoring calcium dynamics with indicators like Fluo-4 o | track mitochondrial movement using fluorescent indicators (MitoTracker Red, mito-GFP) while simultaneously monitoring calcium dynamics with indicators like Fluo | — no observation — | pending | 0.40 |
🔮 Falsifiable Predictions (4)
pendingconf 40%
If hypothesis is true, intervention be implemented. Initial in vitro studies would utilize primary astrocyte-neuron co-cultures transduced with AAV vectors expressing ChR2 under the GFAP promoter
Predicted outcome: be implemented. Initial in vitro studies would utilize primary astrocyte-neuron co-cultures transduced with AAV vectors expressing ChR2 under the GFAP
Falsification: Intervention fails to be implemented. Initial in vitro studies would utilize primary astrocyte-neuron co-cultures transduced with AAV vectors expressing ChR2 under the GFAP promoter
pendingconf 40%
If hypothesis is true, intervention track mitochondrial movement using fluorescent indicators (MitoTracker Red, mito-GFP) while simultaneously monitoring calcium dynamics with indicators like Fluo-4 or GCaMP6
Predicted outcome: track mitochondrial movement using fluorescent indicators (MitoTracker Red, mito-GFP) while simultaneously monitoring calcium dynamics with indicators
Falsification: Intervention fails to track mitochondrial movement using fluorescent indicators (MitoTracker Red, mito-GFP) while simultaneously monitoring calcium dynamics with indicators like Fluo-4 or GCaMP6
pendingconf 40%
If hypothesis is true, intervention potentially be harnessed for therapeutic intervention
Predicted outcome: potentially be harnessed for therapeutic intervention
Falsification: Intervention fails to potentially be harnessed for therapeutic intervention
pendingconf 40%
If hypothesis is true, intervention induce calcium elevations sufficient to trigger gliotransmitter release and influence synaptic transmission
Predicted outcome: induce calcium elevations sufficient to trigger gliotransmitter release and influence synaptic transmission
Falsification: Intervention fails to induce calcium elevations sufficient to trigger gliotransmitter release and influence synaptic transmission
Related Entities
▸Metadata
| status | proposed |
| disease | neurodegeneration |
| target_gene | ChR2 |
| target_pathway | None |
| _schema_version | 1 |
| composite_score | 0.45 |
📊 Evidence Profile
Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
1063
Outgoing
390
0 supporting
0 contradicting
0 neutral
🌍 Provenance Graph
8 nodes, 14 edges
derives from (14)
hypothesis-h-826df660→analysis-SDA-2026-04-01-gap-20analysis-SDA-2026-04-01-gap-20→hypothesis-h-826df660analysis-SDA-2026-04-01-gap-20→hypothesis-h-16ee87a4hypothesis-h-16ee87a4→analysis-SDA-2026-04-01-gap-20analysis-SDA-2026-04-01-gap-20→hypothesis-h-91bdb9ad
▸ Show 9 more
hypothesis-h-91bdb9ad→analysis-SDA-2026-04-01-gap-20analysis-SDA-2026-04-01-gap-20→hypothesis-h-2a4e4ad2hypothesis-h-2a4e4ad2→analysis-SDA-2026-04-01-gap-20analysis-SDA-2026-04-01-gap-20→hypothesis-h-9adb5c9ehypothesis-h-9adb5c9e→analysis-SDA-2026-04-01-gap-20analysis-SDA-2026-04-01-gap-20→hypothesis-h-d78123d1hypothesis-h-d78123d1→analysis-SDA-2026-04-01-gap-20analysis-SDA-2026-04-01-gap-20→hypothesis-h-495454efhypothesis-h-495454ef→analysis-SDA-2026-04-01-gap-20
🗣 Debate History1 session
gap_analysisWhat are the mechanisms underlying mitochondrial transfer between neurons and glia?r5q=0.812026-04-01
This artifact has no version history yet.
Linked Artifacts (1403)
🧬 Related Hypotheses — same target / disease (20)
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration
Score: 0.924 · Target: NLRP3, CASP1, IL1B, PYCARD · neurodegeneration
APOE-Dependent Autophagy Restoration
Score: 0.895 · Target: MTOR · neurodegeneration
Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse
Score: 0.895 · Target: SLC16A1, SLC16A7, LDHA, PDHA1 · neurodegeneration
p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphoryla
Score: 0.895 · Target: MAPK14/PRMT1 · neurodegeneration
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence
Score: 0.893 · Target: SIRT1 · neurodegeneration
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration
Score: 0.892 · Target: TREM2 · neurodegeneration
Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of Microglial
Score: 0.887 · Target: IFNG · neurodegeneration
TREM2-APOE Axis Dissociation for Selective DAM Activation
Score: 0.886 · Target: TREM2-APOE axis · neurodegeneration
Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation
Score: 0.882 · Target: HCRTR1/HCRTR2 · neurodegeneration
Complement Cascade Inhibition Synaptic Protection
Score: 0.867 · Target: — · neurodegeneration
TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Failed DAM Tran
Score: 0.862 · Target: NAMPT · neurodegeneration
H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State
Score: 0.856 · Target: EIF2S1, EIF2AK3/PERK, PPP1R15B, EIF2B · neurodegeneration
Senescent Cell ASM-Complement Cascade Intervention
Score: 0.852 · Target: SMPD1 · neurodegeneration
Prime Editing Precision Correction of APOE4 to APOE3 in Microglia
Score: 0.850 · Target: APOE · neurodegeneration
TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease
Score: 0.847 · Target: TREM2 · neurodegeneration
TYROBP (DAP12) Conditional Antagonism for Early-Stage Neuroprotection
Score: 0.844 · Target: TYROBP · neurodegeneration
Neutral Sphingomyelinase-2 Inhibition for Synaptic Protection in Neurodegeneration
Score: 0.844 · Target: SMPD3 · neurodegeneration
miR-155/Interferon-gamma Feedback Loop as a Reversible Molecular Switch for Protective Mic
Score: 0.843 · Target: MIR155 · neurodegeneration
Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome
Score: 0.839 · Target: SST, SSTR1, SSTR2 · neurodegeneration
Sequential Iron Chelation (Deferoxamine) and GPX4 Restoration (Sulforaphane) Prevents the
Score: 0.838 · Target: Labile iron pool (deferoxamine target) and GPX4 (sulforaphane target) · neurodegeneration
Reference URLs
Embed this artifact
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
HTML iframe
<iframe src="http://scidex.ai/artifact/hypothesis-h-826df660?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
Markdown link
[Optogenetic Control of Mitochondrial Transfer Networks](http://scidex.ai/artifact/hypothesis-h-826df660)
Direct URL
http://scidex.ai/artifact/hypothesis-h-826df660
Preview
🔄 Adjacent Artifacts
Recommended based on your interests
💬 Discussion
Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.